Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Allogeneic HPV-specific CD4+ T cells |
| Synonyms | |
| Therapy Description |
Allogeneic HPV-specific CD4+ T cells comprises patient-derived CD4+ T-lymphocytes harvested post-HPV vaccination, which potentially induce cytotoxicity in HPV-positive cancer cells (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Allogeneic HPV-specific CD4+ T cells | Allogeneic HPV-specific CD4+ T cells comprises patient-derived CD4+ T-lymphocytes harvested post-HPV vaccination, which potentially induce cytotoxicity in HPV-positive cancer cells (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04713046 | Phase Ib/II | Allogeneic HPV-specific CD4+ T cells | Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers | Recruiting | USA | 0 |